is tirzepatide hard on kidneys improves kidney outcomes in T2DM with increased CV risk New Trial Studying Tirzepatide for

It also provides deep antioxidant support to heavily reduce systemic inflammation

Endotext [Internet] Sodhi M, Rezaeianzadeh R, Kezouh A, Etminan M (2023) Risk of Gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss

Renal function and glycemic response should be monitored periodically, particularly during dose escalation and in patients at increased risk of adverse reactions

Lets start here, because this part matters more than most people realize

Inconsistent Weight Loss: While some individuals report continued, albeit slower, weight loss with slightly extended intervals (e.g., 10-11 days), many describe plateaus or even slight weight regain when dosing is stretched further (e.g., 14 days)

Smits RM, Veldhuijzen DS, Wulffraat NM, Evers AWM